Skip to main content
SpringerLink
Log in

Bisphosphonatbedingte Kieferosteonekrose

Empfehlungen zur Prävention und Therapie

Bisphosphonate-induced osteonecrosis of the jaws

Recommendations on prevention and treatment

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Fehm T, Felsenberg D, Krimmel M et al (2009) Bisphosphonate-associated osteonecrosis of the jaw in breast cancer: recommendations for prevention and treatment. Breast 18(4):213–217

    Article  CAS  PubMed  Google Scholar 

  2. Mauri D, Valachis A, Polyzos IP et al (2009) Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast Cancer Res Treat 116(3):433–439

    Article  CAS  PubMed  Google Scholar 

  3. Fehm T, Beck V, Banys M et al (2009) Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol 112(3):605–609

    Article  CAS  PubMed  Google Scholar 

  4. Ripamonti CI, Maniezzo M, Campa T et al (2008) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137–145

    Article  PubMed  Google Scholar 

  5. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369–376

    Article  Google Scholar 

  6. Khosla S, Burr D, Cauley J et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479–1491

    Article  PubMed  Google Scholar 

  7. Khan AA, Sándor GK, Dore E et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35(7):1391–1397

    PubMed  Google Scholar 

  8. Diel IJ, Jaschke A, Solomayer EF et al. (2008) Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up. Ann Oncol 19:2007–2011

    Article  CAS  PubMed  Google Scholar 

  9. Powles T, McCroskey E, Paterson A (2006) Oral bisphosphonates as adjuvant therapy for operable breast cancer. Clin Cancer Res 12:6301–6304s

    Article  Google Scholar 

  10. Saarto T, Vehmanen L, Virkkunen P et al. (2004) Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. Acta Oncol 43(7):650–656

    Article  CAS  PubMed  Google Scholar 

  11. Montefusco V, Gay F, Spina F et al. (2007) Antibiotic prophylaxis before dental procedures can reduce ONJ incidence. ASH Annual Meeting Abstracts 110:3613

    Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

  1. Universitätsfrauenklinik, Eberhard Karls Universität Tübingen, Calwer Str. 7, 72076, Tübingen, Deutschland

    T. Fehm, B. Walter & D. Wallwiener

Authors
  1. T. Fehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Wallwiener
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Fehm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fehm, T., Walter, B. & Wallwiener, D. Bisphosphonatbedingte Kieferosteonekrose. Gynäkologe 43, 517–520 (2010). https://doi.org/10.1007/s00129-010-2572-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-010-2572-y

Search

Navigation